Cargando…

Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles

The coronavirus disease 2019 (COVID-19) is still causing a wide range of infections and deaths due to the high variability of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therefore, it is necessary to establish a reliable and convenient pseudovirus-based neutralization assay to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Sheng, Liu, Lizhen, Wang, Can, Wang, Ziqiang, Duan, Xuhua, Chen, Gang, Zhou, Hu, Shao, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chinese Medical Association Publishing House. Published by Elsevier BV. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721934/ https://www.ncbi.nlm.nih.gov/pubmed/35005601 http://dx.doi.org/10.1016/j.bsheal.2021.12.006

Ejemplares similares

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
por: Nie, Jianhui, et al.
Publicado: (2020)

Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2
por: Neerukonda, Sabari Nath, et al.
Publicado: (2021)

Packaging of Rift Valley fever virus pseudoviruses and establishment of a neutralization assay method
por: Li, Yuetao, et al.
Publicado: (2018)

Establishment of a neutralization assay for Nipah virus using a high-titer pseudovirus system
por: Luo, Xiaoyi, et al.
Publicado: (2023)

A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
por: Donofrio, Gaetano, et al.
Publicado: (2021)

A simple and safe antibody neutralization assay based on polio pseudoviruses
por: Jiang, Zheng, et al.
Publicado: (2018)

A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay
por: Sievers, Benjamin Louis, et al.
Publicado: (2022)

Evaluation of a Pseudovirus Neutralization Assay for SARS-CoV-2 and Correlation with Live Virus-Based Micro Neutralization Assay
por: Tolah, Ahmed Majdi K., et al.
Publicado: (2021)

Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for SARS‐CoV‐2 Variants after Primary and Booster Immunization
por: Xie, Hui, et al.
Publicado: (2022)

Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays
por: Yu, Jingyou, et al.
Publicado: (2021)

Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants
por: Sun, Hancong, et al.
Publicado: (2022)

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
por: Crawford, Katharine H. D., et al.
Publicado: (2020)

A Novel and Secure Pseudovirus Reporter System Based Assay for Neutralizing and Enhancing Antibody Assay Against Marburg Virus
por: Bi, Jinhao, et al.
Publicado: (2022)

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Development of a Cell-Based SARS-CoV-2 Pseudovirus Neutralization Assay Using Imaging and Flow Cytometry Analysis
por: Izac, Jerilyn R., et al.
Publicado: (2023)

Development and Evaluation of a Pseudovirus-Luciferase Assay for Rapid and Quantitative Detection of Neutralizing Antibodies against Enterovirus 71
por: Wu, Xing, et al.
Publicado: (2013)

Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system
por: Nie, Jianhui, et al.
Publicado: (2017)

Analysis of Cross-Reactive Neutralizing Antibodies in Human HFMD Serum with an EV71 Pseudovirus-Based Assay
por: Zhang, Huafei, et al.
Publicado: (2014)

Development of a pseudovirus based assay for measuring neutralizing antibodies against coxsackievirus B5
por: Chen, Pan, et al.
Publicado: (2017)

A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus
por: Hu, Longbo, et al.
Publicado: (2023)

Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
por: Wu, Canhao, et al.
Publicado: (2022)

Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2
por: Hu, Jie, et al.
Publicado: (2020)

Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-Andes orthohantavirus Neutralizing Antibodies in Patient Samples
por: Vial, Cecilia, et al.
Publicado: (2020)

Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum
por: Jin, Jun, et al.
Publicado: (2013)

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells
por: Xiong, Hua-Long, et al.
Publicado: (2020)

Combining MOE Bioinformatics Analysis and In Vitro Pseudovirus Neutralization Assays to Predict the Neutralizing Ability of CV30 Monoclonal Antibody on SARS-CoV-2 Variants
por: Zhu, Yajuan, et al.
Publicado: (2023)

SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD
por: Septisetyani, Endah Puji, et al.
Publicado: (2021)

Performance of commercial SARS-CoV-2 wild-type and Omicron BA.1 antibody assays compared with pseudovirus neutralization tests
por: Habermann, E., et al.
Publicado: (2023)

Establishment of a Pseudovirus Platform for Neuraminidase Inhibiting Antibody Analysis
por: Desheva, Yulia, et al.
Publicado: (2023)

Safe Pseudovirus-based Assay for Neutralization Antibodies against Influenza A(H7N9) Virus
por: Qiu, Chao, et al.
Publicado: (2013)

Comparative analysis of the neutralizing activity against SARS-CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assay
por: D’Apice, Luciana, et al.
Publicado: (2022)

The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus
por: Kim, Yeong Jun, et al.
Publicado: (2021)

Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies
por: Xiang, Qi, et al.
Publicado: (2022)

A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV
por: Zhao, Guangyu, et al.
Publicado: (2013)

Detection of antibodies against H5 and H7 strains in birds: evaluation of influenza pseudovirus particle neutralization tests
por: Wallerström, Sofie, et al.
Publicado: (2014)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

Synergy in monoclonal antibody neutralization of HIV-1 pseudoviruses and infectious molecular clones
por: Miglietta, Riccardo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_todhfsbkabv8i6o3e50epr2fhi